本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Prime Medicine, Inc.

2.01
+0.01000.50%
盘后1.96-0.0500-2.49%19:39 EDT
成交量:206.40万
成交额:428.49万
市值:2.57亿
市盈率:-1.22
高:2.30
开:2.06
低:1.94
收:2.00
数据加载中...

公司资料

公司名字:
Prime Medicine, Inc.
交易所:
NASDAQ
成立时间:
2019
员工人数:
214
公司地址:
21 Erie Street,Cambridge,Massachusetts,United States
邮编:
02139
电话:
传真:
- -
简介:
Prime Medicine, Inc.于2019年9月在特拉华州注册成立。该公司是一家生物技术公司,致力于提供一类新的差异化一次性治疗基因疗法— Prime Editors,通过部署Prime Editing技术来解决最广泛的疾病谱。

董事

名称
职位
Keith Gottesdiener
President, Chief Executive Officer and Director
David Schenkein
Director
Kaye Foster
Director
Michael Kelly
Director
Robert Taylor NELSEN
Director
Thomas Cahill
Director
Wendy Chung
Director

股东

名称
职位
Keith Gottesdiener
President, Chief Executive Officer and Director
Carman Alenson
Interim Chief Financial Officer and Chief Accounting Officer
Meredith Goldwasser
Senior Vice President, Strategy and Corporate Operations
Andrew Anzalone
Senior Scientist II, Head of Prime Editing Platform
Ann Lee
Chief Technical Officer
Jeremy Duffield
Chief Scientific Officer
Richard Brudnick
Chief Business Officer